ORMDL2 Deficiency Potentiates the ORMDL3-Dependent Changes in Mast Cell Signaling.

Area of Science:

• Immunology
• Cell Biology
• Biochemistry

Background:

• Systemic anaphylaxis is a severe allergic reaction driven by mast cells.
• Sphingolipids regulate allergic responses, and ORMDL proteins (ORMDL1, 2, 3) control their synthesis.
• The specific roles of ORMDL2 and ORMDL3 in mast cell signaling remain unclear.

Purpose of the Study:

• To investigate the interplay between ORMDL2 and ORMDL3 in IgE-mediated mast cell activation.
• To elucidate the functions of ORMDL2 and ORMDL3 in mast cell signaling pathways.

Main Methods:

• Generated whole-body knockout (KO) mice lacking Ormdl2 and/or Ormdl3 genes.
• Analyzed mast cell activation, sphingolipid levels, and cytokine production in vitro.
• Assessed allergic responses in vivo using passive cutaneous anaphylaxis (PCA) and passive systemic anaphylaxis models.

Main Results:

• ORMDL3 deficiency increased mast cell sphingolipid levels; combined ORMDL2/3 deficiency further elevated them, including sphingosine-1-phosphate (S1P).
• Double ORMDL2/3 knockout mast cells showed heightened degranulation, cytokine release (IL-4, IL-6, TNF-α), and IκB-α phosphorylation.
• In vivo, passive cutaneous anaphylaxis was exacerbated in ORMDL2,3 double KO mice, while recovery from systemic anaphylaxis was faster in ORMDL3 KO and double KO mice.

Conclusions:

• ORMDL2 deficiency potentiates ORMDL3-dependent alterations in mast cell signaling.
• Combined ORMDL2 and ORMDL3 loss significantly impacts mast cell responsiveness and allergic reactions.
• Sphingolipid metabolism, regulated by ORMDL proteins, is a critical factor in modulating anaphylaxis severity and resolution.